914097-79-3

Upstream product

• 914097-72-6 allyl 2-O-(4-methoxybenzyl)-3,4-O-isopropylidene-6-O-(1-methoxy-1-methylethyl)-β-D-galactopyranoside 
• 914097-74-8 allyl 2-O- (4-methoxylbenzyl)-3,4,6-O-triacetyl-β-D-galactopyranoside 
• 914097-59-9 allyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-β-D-galactopyranosyl-(1,4)-β-D-glucopyranoside 
• 914097-65-7 allyl 2-O-benzoyl-4,6-O-benzylidene-β-D-gulopyranosyl-(1,4)-2,3,6-O-tri-benzoyl-β-D-glucopyranoside 
• 914097-63-5 allyl 2-O-benzoyl-4,6-O-benzylidene-β-D-galactopyranosyl-(1,4)-2,3,6-O-tri-benzoyl-β-D-glucopyranoside 
• 914097-67-9 allyl 2-O-benzoyl-3-S-acetyl-3-thio-3-deoxy-4,6-O-benzylidene-β-D-galactopyranosyl-(1,4)-2,3,6-O-tri-benzoyl-β-D-glucopyranoside 
• 914097-61-3 allyl 2-O-benzoyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-β-D-galactopyranosyl-(1,4)-2,3,6-O-tri-benzoyl-β-D-glucopyranoside 
• 147221-63-4 allyl 3,4-O-isopropylidene-6-O-(1-methoxy-1-methylethyl)-β-D-galactopyranoside 
• 227601-47-0 allyl-O-<3-O-(4-methoxybenzyl)-β-D-galactopyranosyl>-(1->4)-β-D-glucopyranoside 
• 52211-61-7 (2S,3R,4S,5R,6R)-2-(((2R,3S,4R,5R,6R)-6-(allyloxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 2595-07-5 allyl β-D-galactopyranoside 
• 914097-76-0 3,4,6-tri-O-acetyl-2-O-(4-methoxybenzyl)-α-D-galactopyranosyl trichloroacetimidate 
• 914097-69-1 C₅₀H₄₆O₁₄S 

Downstream Products

• 914097-82-8 2-O-(4-methoxybenzyl)-3,4,6-tri-O-acetyl-α-D-galactopyranosyl-(1,3)-2-O-benzoyl-3-thio-3-deoxy-4,6-O-benzylidene-β-D-galactopyranosyl-(1,4)-2,3,6-tri-O-benzoyl-α-D-glucopyranosyl-trichloroacetimide 

Relevant academic research and scientific papers

Thio-isoglobotrihexosylceramide, an agonist for activating invariant natural killer T cells

Thio-isoglobotrihexosylceramide (S-iGb3) might be resistant to α-galactosidases in antigen-presenting cells and have a longer retaining time in the lysosome before being loaded to CD1d. The biological assay showed that S-iGb3 demonstrates a much higher in